| Title : Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Abeta-aggregation inhibitors: Synthesis and biological evaluation - Mohamed_2011_Bioorg.Med.Chem.Lett_21_5881 |
| Author(s) : Mohamed T , Yeung JC , Rao PP |
| Ref : Bioorganic & Medicinal Chemistry Lett , 21 :5881 , 2011 |
| Abstract : A group of 2-substituted N-(naphth-1-ylmethyl)pyrimidin-4-amines (6a-k) and N-benzhydrylpyrimidin-4-amines (7a-k) in conjunction with varying steric and electronic properties at the C-2 position were designed, synthesized and evaluated as dual cholinesterase and amyloid-beta (Abeta)-aggregation inhibitors. The naphth-1-ylmethyl compound 6f (2-(4-cyclohexylpiperazin-1-yl)-N-(naphth-1-ylmethyl)pyrimidin-4-amine) exhibited optimum dual ChE (AChE IC(50)=8.0 muM, BuChE IC(50)=3.9 muM) and hAChE-promoted Abeta-aggregation inhibition (30.8% at 100 muM), whereas in the N-benzhydryl series, compound 7f (N-benzhydryl-2-(4-cyclohexylpiperazin-1-yl)pyrimidin-4-amine) exhibited optimum combination of dual ChE (AChE IC(50)=10.0 muM, BuChE IC(50)=7.6muM) and hAChE-promoted Abeta-aggregation inhibition (32% at 100 muM). These results demonstrate that a 2,4-disubstituted pyrimidine ring serves as a suitable template to target multiple pathological routes in AD, with a C-2 cyclohexylpiperazine substituent providing dual ChE inhibition and potency whereas a C-4 diphenylmethane substituent provides Abeta-aggregation inhibition. |
| ESTHER : Mohamed_2011_Bioorg.Med.Chem.Lett_21_5881 |
| PubMedSearch : Mohamed_2011_Bioorg.Med.Chem.Lett_21_5881 |
| PubMedID: 21873056 |
Mohamed T, Yeung JC, Rao PP (2011)
Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Abeta-aggregation inhibitors: Synthesis and biological evaluation
Bioorganic & Medicinal Chemistry Lett
21 :5881
Mohamed T, Yeung JC, Rao PP (2011)
Bioorganic & Medicinal Chemistry Lett
21 :5881